AOCI at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s AOCI?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported AOCI of $1.08M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s AOCI changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s AOCI increased by 178.1% year-over-year, from $389K to $1.08M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s AOCI?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s AOCI has grown at a 79.4% compound annual growth rate (CAGR), from $47K to $873K.
- What does AOCI mean?
- Cumulative unrealized gains or losses not included in net income.
- How do you interpret AOCI?
- Fluctuations reflect external market factors like interest rate changes or currency volatility rather than operational success.
- How does AOCI compare across companies?
- Varies significantly based on a company's exposure to international markets and hedging strategies.